Product NDC: | 15054-0120 |
Proprietary Name: | Somatuline Depot |
Non Proprietary Name: | lanreotide acetate |
Active Ingredient(s): | 120 mg/.5mL & nbsp; lanreotide acetate |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 15054-0120 |
Labeler Name: | Ipsen Biopharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022074 |
Marketing Category: | NDA |
Start Marketing Date: | 20071114 |
Package NDC: | 15054-0120-1 |
Package Description: | 1 POUCH in 1 CARTON (15054-0120-1) > 1 SYRINGE in 1 POUCH > .5 mL in 1 SYRINGE |
NDC Code | 15054-0120-1 |
Proprietary Name | Somatuline Depot |
Package Description | 1 POUCH in 1 CARTON (15054-0120-1) > 1 SYRINGE in 1 POUCH > .5 mL in 1 SYRINGE |
Product NDC | 15054-0120 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | lanreotide acetate |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20071114 |
Marketing Category Name | NDA |
Labeler Name | Ipsen Biopharmaceuticals, Inc. |
Substance Name | LANREOTIDE ACETATE |
Strength Number | 120 |
Strength Unit | mg/.5mL |
Pharmaceutical Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |